Fig. 7: Peak antibody and cellular response after third vaccine do not correlate with protection against breakthrough. | Nature Aging

Fig. 7: Peak antibody and cellular response after third vaccine do not correlate with protection against breakthrough.

From: Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes

Fig. 7

a, Kaplan–Meier curve showing the probability of infection from third vaccine in recipients who had follow-up screening after vaccination. Follow-up time began 7 d after the third vaccine (n = 305, 81 positive PCR or LFD). The 95% confidence intervals (CIs) are shown in a lighter shade. b, Kaplan–Meier curve showing the probability of infection from third vaccine in recipients stratified by <65 and ≥65 years of age. Follow-up time began 7 d after the third vaccine (blue, <65 years, 54 positive test; green, ≥65 years, 27 positive test, n = 305, log-rank P = 0.099). The 95% CIs are shown in a lighter shade. c, Kaplan–Meier curve of the probability of infection in relation to spike-specific antibody response above predicted (green) or below predicted (red) median over the subsequent 120 d. Cox proportional hazards regression model: hazard ratio, 0.96 (95% CI 0.45–2.06, P = 0.93), n = 122 participants. d, Kaplan–Meier curve of the probability of infection in relation to spike-specific cellular response above (green) or below (red) predicted median over the subsequent 120 d. Cox proportional hazards regression model: hazard ratio, 0.81 (95% CI 0.37–1.74, P = 0.59), n = 122 participants.

Back to article page